| Domestic Pharmaceutical Market | Manufacturing and sale of pharmaceutical products across 12 therapeutic segments including orthopaedics and cardiology. | Extensive product portfolio, WHO certification, diversified business models including third-party manufacturing. | B2B and B2C including hospitals, pharmacies, and government agencies. | Specialty therapeutic segments like dermatology and sexual wellness. | 26 | 75 | Revenue from product sales through brand business and government supplies. | Direct sales with bulk contracts and retail pricing. | Expanding product approvals, government contracts, and rising domestic healthcare demand. | |
| Export Markets | Exports of pharmaceutical and nutraceutical products to countries in Asia and Africa. | Regulatory approvals and manufacturing certifications enabling international market access. | Global B2B buyers and distributors in developing markets. | Nutraceutical and ayurvedic product exports. | 4 | 13 | Sales revenue from international distributors and partners. | Contract-based export sales. | Growing healthcare needs in export regions and expanding product registrations. | |
